Farallon Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,465,000
| Closed | -$2.43M | – | 177 |
|
|
2023
Q1 | $2.43M | Sell |
1,465,000
-652,600
| -31% | -$1.08M | 0.01% | 134 |
|
|
2022
Q4 | $4.07M | Sell |
2,117,600
-782,400
| -27% | -$1.5M | 0.02% | 155 |
|
|
2022
Q3 | $6.5M | Hold |
2,900,000
| – | – | 0.04% | 164 |
|
|
2022
Q2 | $9.4M | Hold |
2,900,000
| – | – | 0.05% | 140 |
|
|
2022
Q1 | $15.3M | Buy |
2,900,000
+1,470,000
| +103% | +$7.73M | 0.07% | 111 |
|
|
2021
Q4 | $12.2M | Sell |
1,430,000
-780,000
| -35% | -$6.63M | 0.06% | 115 |
|
|
2021
Q3 | $22M | Sell |
2,210,000
-288,600
| -12% | -$2.87M | 0.1% | 95 |
|
|
2021
Q2 | $23.3M | Sell |
2,498,600
-1,400
| -0.1% | -$13K | 0.1% | 93 |
|
|
2021
Q1 | $26.1M | Hold |
2,500,000
| – | – | 0.13% | 92 |
|
|
2020
Q4 | $29.3M | Buy |
+2,500,000
| New | +$29.3M | 0.18% | 80 |
|